Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CollPlant Biotechnologies (CLGN) Non Operating Income (2017 - 2019)

CollPlant Biotechnologies filings provide 3 years of Non Operating Income readings, the most recent being -$5.5 million for Q4 2019.

  • On a quarterly basis, Non Operating Income fell 180.72% to -$5.5 million in Q4 2019 year-over-year; TTM through Dec 2019 was -$6.0 million, a 185.8% decrease, with the full-year FY2025 number at -$6000.0, down 100.93% from a year prior.
  • Non Operating Income hit -$5.5 million in Q4 2019 for CollPlant Biotechnologies, down from $1.6 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $1.6 million in Q3 2019 to a low of -$5.5 million in Q4 2019.
  • Median Non Operating Income over the past 3 years was -$81000.0 (2017), compared with a mean of -$872285.7.
  • Biggest five-year swings in Non Operating Income: crashed 2320.99% in 2018 and later soared 845.45% in 2019.
  • CollPlant Biotechnologies' Non Operating Income stood at -$81000.0 in 2017, then crashed by 2320.99% to -$2.0 million in 2018, then plummeted by 180.72% to -$5.5 million in 2019.
  • The last three reported values for Non Operating Income were -$5.5 million (Q4 2019), $1.6 million (Q3 2019), and -$68000.0 (Q2 2019) per Business Quant data.